Side population and cancer stem cells: Therapeutic implications

Lidia Moserle, Margherita Ghisi, Alberto Amadori, Stefano Indraccolo

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

New studies indicate that the side population (SP) and cancer stem cells (CSC) drive and maintain many types of human malignancies. SP and CSC appear to be highly resistant to chemo- and radio-therapy and this knowledge is now reshaping our therapeutic approach to cancer. Several studies have pioneered the possibility of specifically targeting CSC and SP cells by exploiting pathways involved in drug resistance, or forcing these cells to proliferate and differentiate thus converting them into a target of conventional therapies. Moreover, certain cytokines - such as IFN-α - appear to modulate SP and stem cell functions, and this associates with remarkable therapeutic activity in animal models. These recent findings underscore the need of a more comprehensive view of the interactions between cytokines and key regulatory pathways in SP and CSC.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalCancer Letters
Volume288
Issue number1
DOIs
Publication statusPublished - Feb 1 2010

Fingerprint

Neoplastic Stem Cells
Side-Population Cells
Population
Cytokines
Therapeutics
Radio
Drug Resistance
Neoplasms
Stem Cells
Animal Models

Keywords

  • Cancer stem cells
  • Chemotherapy
  • Interferon
  • Side population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Side population and cancer stem cells : Therapeutic implications. / Moserle, Lidia; Ghisi, Margherita; Amadori, Alberto; Indraccolo, Stefano.

In: Cancer Letters, Vol. 288, No. 1, 01.02.2010, p. 1-9.

Research output: Contribution to journalArticle

@article{acf1a99ece8b4beba0e5c092b6f3e001,
title = "Side population and cancer stem cells: Therapeutic implications",
abstract = "New studies indicate that the side population (SP) and cancer stem cells (CSC) drive and maintain many types of human malignancies. SP and CSC appear to be highly resistant to chemo- and radio-therapy and this knowledge is now reshaping our therapeutic approach to cancer. Several studies have pioneered the possibility of specifically targeting CSC and SP cells by exploiting pathways involved in drug resistance, or forcing these cells to proliferate and differentiate thus converting them into a target of conventional therapies. Moreover, certain cytokines - such as IFN-α - appear to modulate SP and stem cell functions, and this associates with remarkable therapeutic activity in animal models. These recent findings underscore the need of a more comprehensive view of the interactions between cytokines and key regulatory pathways in SP and CSC.",
keywords = "Cancer stem cells, Chemotherapy, Interferon, Side population",
author = "Lidia Moserle and Margherita Ghisi and Alberto Amadori and Stefano Indraccolo",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.canlet.2009.05.020",
language = "English",
volume = "288",
pages = "1--9",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Side population and cancer stem cells

T2 - Therapeutic implications

AU - Moserle, Lidia

AU - Ghisi, Margherita

AU - Amadori, Alberto

AU - Indraccolo, Stefano

PY - 2010/2/1

Y1 - 2010/2/1

N2 - New studies indicate that the side population (SP) and cancer stem cells (CSC) drive and maintain many types of human malignancies. SP and CSC appear to be highly resistant to chemo- and radio-therapy and this knowledge is now reshaping our therapeutic approach to cancer. Several studies have pioneered the possibility of specifically targeting CSC and SP cells by exploiting pathways involved in drug resistance, or forcing these cells to proliferate and differentiate thus converting them into a target of conventional therapies. Moreover, certain cytokines - such as IFN-α - appear to modulate SP and stem cell functions, and this associates with remarkable therapeutic activity in animal models. These recent findings underscore the need of a more comprehensive view of the interactions between cytokines and key regulatory pathways in SP and CSC.

AB - New studies indicate that the side population (SP) and cancer stem cells (CSC) drive and maintain many types of human malignancies. SP and CSC appear to be highly resistant to chemo- and radio-therapy and this knowledge is now reshaping our therapeutic approach to cancer. Several studies have pioneered the possibility of specifically targeting CSC and SP cells by exploiting pathways involved in drug resistance, or forcing these cells to proliferate and differentiate thus converting them into a target of conventional therapies. Moreover, certain cytokines - such as IFN-α - appear to modulate SP and stem cell functions, and this associates with remarkable therapeutic activity in animal models. These recent findings underscore the need of a more comprehensive view of the interactions between cytokines and key regulatory pathways in SP and CSC.

KW - Cancer stem cells

KW - Chemotherapy

KW - Interferon

KW - Side population

UR - http://www.scopus.com/inward/record.url?scp=73649139235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649139235&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.05.020

DO - 10.1016/j.canlet.2009.05.020

M3 - Article

C2 - 19523754

AN - SCOPUS:73649139235

VL - 288

SP - 1

EP - 9

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -